Visceral pleural invasion is an invasive and aggressive indicator of nonsmall cell lung cancer

P. Van Schil

Source: Breathe 2006; 2: 264
Journal Issue: March

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Van Schil. Visceral pleural invasion is an invasive and aggressive indicator of nonsmall cell lung cancer. Breathe 2006; 2: 264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oncodrivers in malignant pleural effusions associated with non-small cell lung cancer
Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema
Year: 2020


Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006

Do cavitating non-small cell lung cancer patients have a more aggressive disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Factors affecting the prognosis of nonsmall cell lung cancer with chest wall-parietal pleural invasion (T3) following resection
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Breast metastasis in association with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005

Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016

Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006


Expression of βig-h3 as a marker of local tumor invasion in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 770s
Year: 2006

How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015



Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017


Bronchoscopic treatment of inoperable nonsmall cell lung cancer
Source: Eur Respir Rev, 29 (158) 200035; 10.1183/16000617.0035-2020
Year: 2020



Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
Source: Eur Respir Rev 2015; 25: 65-70
Year: 2016



Possibility of the specific efficacy of gefitinib for miliary lung metastasis in non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 303s
Year: 2004

Bronchoscopic intratumoural therapies for non-small cell lung cancer
Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020
Year: 2020



Metastatic disease in non-small cell lung cancer: is it all the same?
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer
Source: Breathe, 14 (4) 342; 10.1183/20734735.027118
Year: 2018



Diagnostic significance of ADAM8 in non-small cell lung cancer and malignant pleural effusion
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008

A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005

Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease?
Source: Eur Respir J, 53 (3) 1801508; 10.1183/13993003.01508-2018
Year: 2019